Complement Levels and Risk of Organ Involvement in Patients with Systemic Lupus Erythematosus
Abu Al-Fadl, E., Radwan, A., Ali, A., Masoud, A. (2019). Complement Levels and Risk of Organ Involvement in Patients with Systemic Lupus Erythematosus. EKB Journal Management System, 2(2), 50-56. doi: 10.21608/svuijm.2019.122274
Esam M. Abu Al-Fadl; Ahmed R. Radwan; Abdallah E.M. Ali; Abeer H. Masoud. "Complement Levels and Risk of Organ Involvement in Patients with Systemic Lupus Erythematosus". EKB Journal Management System, 2, 2, 2019, 50-56. doi: 10.21608/svuijm.2019.122274
Abu Al-Fadl, E., Radwan, A., Ali, A., Masoud, A. (2019). 'Complement Levels and Risk of Organ Involvement in Patients with Systemic Lupus Erythematosus', EKB Journal Management System, 2(2), pp. 50-56. doi: 10.21608/svuijm.2019.122274
Abu Al-Fadl, E., Radwan, A., Ali, A., Masoud, A. Complement Levels and Risk of Organ Involvement in Patients with Systemic Lupus Erythematosus. EKB Journal Management System, 2019; 2(2): 50-56. doi: 10.21608/svuijm.2019.122274

Complement Levels and Risk of Organ Involvement in Patients with Systemic Lupus Erythematosus

SVU-International Journal of Medical Sciences
Article 9, Volume 2, Issue 2, July 2019, Page 50-56  XML PDF (275.65 K)
Document Type: Original research articles
DOI: 10.21608/svuijm.2019.122274
View on SCiNiTO View on SCiNiTO
Authors
Esam M. Abu Al-Fadl1; Ahmed R. Radwan1; Abdallah E.M. Ali2; Abeer H. Masoud1
1Rheumatology Department, Faculty of Medicine, Sohag University, Sohag, Egypt
2Clinical Pathology Department, Faculty of Medicine, South Valley University, Qena, Egypt
Abstract
Objectives: to estimate the effect of complement level changes on clinical manifestations, visceral damage and
mortality in our patients with SLE.
Patients and method(s): A cross sectional study including 50 patients attending to South Valley University
Hospitals have been included in the study for assessment of complement levels in patients with SLE and
correlating complement levels with renal, neuropsychiatric, cardiac and hematological manifestations of SLE.
Result(s): The most common organ system involved was the musculoskeletal system, with arthritis in 76% of
the cases. This was followed by cutaneous manifestations (72%), then lupus nephritis (62%), CNS lupus (44%),
hematological (30%) and lastly CVS (12%). Non of our cases showed liver impairment. Around two thirds of
patients with renal involvement had consumed complement, compared to only 26% among those with no renal
involvement; with a significant difference. It also shows that there is no significant difference between
hypertension and complement level. Over 72% of patients with CNS involvement had consumed complement,
compared to only 32% among those with no CNS involvement; with a significant difference. There is no
significant relation between blood disorders, arthritis, mucocutaneous in lupus patients and complement
consumption.
Conclusion: Our study suggested that complement consumption was strongly associated with lupus nephritis
and to a lesser extent; CNS lupus, but not with other organ involvement in SLE patients.
Keywords
SLE; Complement; Organ involvement
Statistics
Article View: 148
PDF Download: 223